Address correspondence to Dr Horacio Kaufmann, NYU Langone Health, 530 First Ave, Suite 9Q–Dysautonomia Center, New York, NY 10016, Horacio.Kaufmann@nyulangone.org.
RELATIONSHIP DISCLOSURE: Dr Palma serves as managing editor for Clinical Autonomic Research and as a consultant for Biogen, Dr Reddy’s Laboratories Ltd, Lundbeck, and PTC Therapeutics. Dr Palma receives research/grant support from the Familial Dysautonomia Foundation, Inc; the Michael J. Fox Foundation for Parkinson’s Research; the Multiple System Atrophy Coalition; and the National Institute of Neurological Disorders and Stroke (R01NS107596, U54NS065736). Dr Kaufmann serves as editor-in-chief of Clinical Autonomic Research and as a consultant for and on the scientific advisory boards of Biogen, Biohaven Pharmaceuticals, Lundbeck, and Pfizer Inc. Dr Kaufmann receives research/grant support from the Familial Dysautonomia Foundation, Inc; the Michael J. Fox Foundation for Parkinson's Research; the Multiple System Atrophy Coalition; the National Institutes of Health (R01HL103988, U54NS065736); Theravance Biopharma; and the US Food and Drug Administration (FDR3731-01) and publishing royalties from UpToDate, Inc. Dr Kaufmann has served as an expert witness for the Department of Justice regarding the alleged relationship between human papilloma virus vaccination and autonomic disorders.
UNLABELED USE OF PRODUCTS/INVESTIGATIONAL USE DISCLOSURE: Drs Palma and Kaufmann discuss the unlabeled/investigational use of acarbose, ampreloxetine, atomoxetine, erythropoietin, fludrocortisone, octreotide, and pyridostigmine for the treatment of orthostatic hypotension.